Polynovo Ltd (AU:PNV) — Market Cap & Net Worth
Market Cap & Net Worth: Polynovo Ltd (PNV)
Polynovo Ltd (AU:PNV) has a market capitalization of $486.37 Million (AU$687.39 Million) as of May 3, 2026. Listed on the AU stock exchange, this Australia-based company holds position #12671 globally and #321 in its home market, demonstrating a -2.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Polynovo Ltd's stock price AU$1.00 by its total outstanding shares 690842991 (690.84 Million). Analyse PNV cash flow metrics to see how efficiently the company converts income to cash.
Polynovo Ltd Market Cap History: 2015 to 2026
Polynovo Ltd's market capitalization history from 2015 to 2026. Data shows growth from $141.76 Million to $486.37 Million (20.87% CAGR).
Index Memberships
Polynovo Ltd is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$1.97 Trillion | 0.02% | #228 of 495 |
|
S&P/ASX All Australian 200
AXAT
|
$1.88 Trillion | 0.03% | #178 of 200 |
|
S&P/ASX 300
AXKO
|
$2.13 Trillion | 0.02% | #224 of 300 |
|
ASX Small Ordinaries
AXSO
|
$294.63 Billion | 0.17% | #132 of 200 |
Weight: Polynovo Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Polynovo Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Polynovo Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.73x
Polynovo Ltd's market cap is 4.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
45.50x
Polynovo Ltd's market cap is 45.50 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $141.76 Million | $3.28 Million | -$3.06 Million | 43.26x | N/A |
| 2017 | $254.18 Million | $3.62 Million | -$5.01 Million | 70.22x | N/A |
| 2018 | $290.85 Million | $6.55 Million | -$5.97 Million | 44.38x | N/A |
| 2019 | $962.97 Million | $14.04 Million | -$3.19 Million | 68.57x | N/A |
| 2020 | $1.90 Billion | $22.16 Million | -$4.19 Million | 85.60x | N/A |
| 2021 | $745.44 Million | $29.16 Million | -$4.61 Million | 25.57x | N/A |
| 2022 | $987.41 Million | $41.44 Million | -$1.19 Million | 23.83x | N/A |
| 2023 | $808.99 Million | $65.24 Million | -$4.92 Million | 12.40x | N/A |
| 2024 | $997.18 Million | $103.19 Million | $5.26 Million | 9.66x | 189.54x |
| 2025 | $601.24 Million | $127.24 Million | $13.21 Million | 4.73x | 45.50x |
Competitor Companies of PNV by Market Capitalization
Companies near Polynovo Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Polynovo Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Polynovo Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Polynovo Ltd's market cap moved from $141.76 Million to $ 486.37 Million, with a yearly change of 20.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$486.37 Million | -19.11% |
| 2025 | AU$601.24 Million | -39.71% |
| 2024 | AU$997.18 Million | +23.26% |
| 2023 | AU$808.99 Million | -18.07% |
| 2022 | AU$987.41 Million | +32.46% |
| 2021 | AU$745.44 Million | -60.70% |
| 2020 | AU$1.90 Billion | +96.95% |
| 2019 | AU$962.97 Million | +231.09% |
| 2018 | AU$290.85 Million | +14.42% |
| 2017 | AU$254.18 Million | +79.31% |
| 2016 | AU$141.76 Million | 0.00% |
| 2015 | AU$141.76 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Polynovo Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $486.37 Million USD |
| MoneyControl | $486.37 Million USD |
| MarketWatch | $486.37 Million USD |
| marketcap.company | $486.37 Million USD |
| Reuters | $486.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more